Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 86

Enbrel^® was developed by researchers at Immunex. Today the drug is co‐marketed in North America by Amgen and Pfizer, by Takeda Pharmaceuticals in Japan, and by Wyeth in the rest of the world.

Indication: Rheumatoid arthritis, plaque psoriasis, psoriatic arthritis

Manufacturer: Pfizer/Amgen

Global Sales in 2017: $7.9 billion

Generic name: Etanercept

Launch date: 1998